57
Views
14
CrossRef citations to date
0
Altmetric
Review

Inflammatory processes and Alzheimer’s disease

&
Pages 793-798 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vincenzo Solfrizzi, Francesco Panza, Vincenza Frisardi, Davide Seripa, Giancarlo Logroscino, Bruno P Imbimbo & Alberto Pilotto. (2011) Diet and Alzheimer’s disease risk factors or prevention: the current evidence. Expert Review of Neurotherapeutics 11:5, pages 677-708.
Read now
Martina Chiappelli, Emanuela Tumini, Elisa Porcellini & Federico Licastro. (2006) Impaired regulation of immune responses in cognitive decline and Alzheimer’s disease: lessons from genetic association studies. Expert Review of Neurotherapeutics 6:9, pages 1327-1336.
Read now

Articles from other publishers (12)

Ritesh P. Bhole, Rupesh V. Chikhale & Karishma M. Rathi. (2023) Current Biomarkers and Treatment Strategies in Alzheimer Disease: An Overview and Future Perspectives. IBRO Neuroscience Reports.
Crossref
Matheus de Freitas Silva, Ellen Tardelli Lima, Letizia Pruccoli, Newton Castro, Marcos Guimarães, Fernanda da Silva, Nathalia Fonseca Nadur, Luciana de Azevedo, Arthur Kümmerle, Isabella Guedes, Laurent Dardenne, Vanessa Gontijo, Andrea Tarozzi & Claudio Viegas. (2020) Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer’s Disease. Molecules 25:14, pages 3165.
Crossref
Petra Majerova, Monika Zilkova, Zuzana Kazmerova, Andrej Kovac, Kristina Paholikova, Branislav Kovacech, Norbert Zilka & Michal Novak. (2014) Microglia display modest phagocytic capacity for extracellular tau oligomers. Journal of Neuroinflammation 11:1.
Crossref
Norbert Zilka, Zuzana Kazmerova, Santosh Jadhav, Peter Neradil, Aladar Madari, Dominika Obetkova, Ondrej Bugos & Michal Novak. (2012) Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. Journal of Neuroinflammation 9:1.
Crossref
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, Shu-Pang Huang, Randy Slemmon, Robert Croop, Lorna Castaneda, Huidong Gu, Oi Wong, Hewei Li, Robert M. Berman, Christina Smith, Charles F. Albright & Randy C. Dockens. (2012) Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers. Clinical Therapeutics 34:3, pages 654-667.
Crossref
Arundhati Jana & Kalipada Pahan. (2010) Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease. The Journal of Neuroscience 30:38, pages 12676-12689.
Crossref
Debra LyonChing-Yu Cheng, Lois Howland, Debra Rattican, Nancy Jallo, Rita Pickler, Lisa Brown & Jacqueline McGrath. (2009) Integrated Review of Cytokines in Maternal, Cord, and Newborn Blood: Part I—Associations With Preterm Birth. Biological Research For Nursing 11:4, pages 371-376.
Crossref
Norbert Zilka, Zuzana Stozicka, Andrej Kovac, Emil Pilipcinec, Ondrej Bugos & Michal Novak. (2009) Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy. Journal of Neuroimmunology 209:1-2, pages 16-25.
Crossref
Rick A.C.M. Boonen, Paula van Tijn & Danica Zivkovic. (2009) Wnt signaling in Alzheimer's disease: Up or down, that is the question. Ageing Research Reviews 8:2, pages 71-82.
Crossref
Martin Philpott & Lynnette Ferguson. 2007. Personalized Nutrition. Personalized Nutrition 49 59 .
I. Glezer, A.R. Simard & S. Rivest. (2007) Neuroprotective role of the innate immune system by microglia. Neuroscience 147:4, pages 867-883.
Crossref
Paul S Aisen. (2005) Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?. Nature Clinical Practice Neurology 1:1, pages 20-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.